Referral to emergency

If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or seek emergent medical advice if in a remote region.

  • acute cholecystitis
  • cholangitis
  • obstructive jaundice with any of the following:
    • pain
    • haemodynamic instability
    • bilirubin greater than 100μmol/L

Please contact the on-call registrar to discuss your concerns prior to referral.

For clinical advice, please telephone the relevant metropolitan Local Health Network switchboard and ask to speak to the relevant specialty service.

Central Adelaide Local Health Network

Northern Adelaide Local Health Network

Southern Adelaide Local Health Network

Category 1 (appointment clinically indicated within 30 days)

  • suspected malignancy
  • painless obstructive jaundice
  • biliary dilatation

Category 2 (appointment clinically indicated within 90 days)

  • nil

Category 3 (appointment clinically indicated within 365 days)

  • nil

For information on referral forms and how to import them, please view general referral information.

Essential referral information

Completion required before first appointment to ensure patients are ready for care. Please indicate in the referral if the patient is unable to access mandatory tests or investigations as they incur a cost or are unavailable locally.

  • identifies as Aboriginal and/or Torres Strait Islander  
  • relevant social history, including identifying if you feel your patient is from a vulnerable population and/or requires a third party to receive correspondence on their behalf
  • interpreter required
  • past medical/surgical history
  • family history of biliary malignancy
  • medications and allergies
  • smoking/alcohol and other drug status
  • age
  • height/weight
  • body mass index
  • history of presenting complaint
    • concerning features, for example,  nausea/vomiting, abdominal pain, dark urine, pale stools, pruritis
    • duration and frequency of symptoms
    • alcohol consumption and frequency
    • previous management trialled and efficacy
  • pathology
    • complete blood examination (CBE)
    • electrolytes urea and creatinine (EUC)
    • liver function test (LFT)
    • glycated haemoglobin (HbA1c) if diabetic
    • coagulation studies
    • c-reactive protein (CRP)
    • lipase/amylase
    • alpha fetoprotein (AFP)
    • cancer antigen 19.9 (CA19.9)
  • abdominal xray (sentinel loop; calcification)
  • abdominal ultrasound (US)
  • chest-abdomen-pelvis with contrast computed tomography (CT)
  • reports of prior gastroscopies and pathology results of specimens
  • relevant diagnostic/imaging reports including location of company and accession number